Categories: News

ICU Medical Announces Time of Second Quarter 2023 Earnings Conference Call

SAN CLEMENTE, Calif., July 24, 2023 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2023 earnings release and conference call.

The Company will release its second quarter 2023 results on Monday, August 7th, 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Monday, August 7th, 2023. The call can be accessed at (833) 816-1376, conference ID 10180958. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company’s website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.

About ICU Medical

ICU Medical (Nasdaq:ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.

CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John Mills, Managing Partner
(646) 277-1254

Source: ICU Medical, Inc.

Staff

Recent Posts

Ivim Health Supports the Outsourcing Facilities Association’s Appeal of Court Ruling That Further Restricts Access to Compounded GLP-1 Medications

Recent Federal Court Ruling Denying Request for an Injunction Will Endanger Patients by Limiting Access…

2 hours ago

AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on…

7 hours ago

TruBridge Announces Fourth Quarter and Full Year 2024 Results and Provides Initial 2025 Outlook

Revenue of $339.2 million for 2024 and $87.4 million in the fourth quarter Net loss…

7 hours ago

PreveCeutical Announces Update to Private Placement

Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB:…

8 hours ago

HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients

HealthTree App Offers Patient Support, Education, and Research Participation in One Seamless Platform SALT LAKE…

8 hours ago

Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum

BURLINGTON, Mass., March 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y.…

8 hours ago